by The European Committee for Treatment and Research in Multiple Sclerosis
The world is better when its people are connected. The ECTRIMS Podcast aims to be a sounding board for MS experts & advocates to discuss innovative work in MS research, treatment and care with the greater MS research community, while offering a collaborative platform for MS and healthcare experts to promote & nurture the advancement of research.
Language
🇺🇲
Publishing Since
10/17/2022
Email Addresses
1 available
Phone Numbers
0 available
March 27, 2025
<p>Autologous haematopoietic <span class="glossary" data-link= "https://www.msaustralia.org.au/glossary/#glossary-stem-cell" data-content= "The human body is made up of different kinds of specialised cells such as muscle cells, nerve cells, fat cells and skin cells. All specialised cells originate from stem cells. A stem cell is a cell that is not yet specialised, and specialises into a specific cell type. Stem cells can be further separated into categories depending on whether they have started the specialisation process, for example haematopoietic stem cells are cells which can give rise to all the different haematopoietic cells.">stem cell</span> transplantation (AHSCT) has gained considerable attention in recent years as a treatment option for multiple sclerosis (MS). As long-term clinical trial data on AHSCT continues to grow, there is increasing debate about where it fits in the current MS therapeutic landscape.</p> <p>Dr. Joachim Burman, Neurologist and Associate Professor at Uppsala University in Sweden, and Dr. Jennifer Massey, Neurologist at St. Vincent's Hospital and a Senior Lecturer at the University of New South Wales in Australia, discuss the latest research and insights on this hot topic with host Brett Drummond of MStranslate.</p>
February 20, 2025
<p class="MsoNormal">The rise of multiple sclerosis (MS) registries worldwide has transformed MS research, providing access to vast clinical data spanning years. This development also triggers critical conversations about how best to use real-world data to answer questions over the treatment of people with MS and the potential shift towards personalised medicine. In this episode, guests <strong>Professor Tomas Kalincik, Head of the Clinical Outcomes Research (CORe) Unit at the University of Melbourne and the MS Centre at the Royal Melbourne Hospital</strong> in Australia, and <strong>Maria Pia Sormani, Professor of Biostatistics at the University of Genoa</strong> in Italy, share their expert insights on harnessing real-world data with host Brett Drummond of MStranslate.</p>
January 14, 2025
Dr. Anne-Laure Dubessy and Professor Iris-Katharina Penner share insights on managing MS-related fatigue with host Brett Drummond, highlighting the latest research and effective strategies for improving quality of life.
BMJ Group
American Academy of Neurology
American Academy of Neurology
Neurology Exam Prep Podcast
Barry Singer, MD
Jon Strum
Dr Rangan Chatterjee: GP & Author
Overcoming MS
Mel Robbins
ZOE
MS Australia
American Academy of Neurology
Dr. Gretchen Hawley PT, DPT, MSCS
DOAC
New York Times Opinion
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at [email protected] for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.